CCP
GILD icon

Cardan Capital Partners’s Gilead Sciences GILD Stock Holding History

Cardan Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-49,312
Closed -$3.12M – 232
2020
Q3 		$3.12M Buy
49,312
+2,435
+5% +$169K 0.41% 81
2020
Q2 		$3.61M Buy
46,877
+239
+0.5% +$18.3K 0.52% 63
2020
Q1 		$3.49M Sell
46,638
-1,128
-2% -$77.9K 0.58% 47
2019
Q4 		$3.1M Buy
47,766
+533
+1% +$34.7K 0.42% 64
2019
Q3 		$2.99M Buy
47,233
+2,240
+5% +$146K 0.43% 64
2019
Q2 		$3.04M Buy
44,993
+1,646
+4% +$108K 0.46% 63
2019
Q1 		$2.82M Sell
43,347
-30
-0.1% -$1.99K 0.46% 61
2018
Q4 		$2.71M Buy
43,377
+451
+1% +$31.5K 0.48% 61
2018
Q3 		$3.31M Sell
42,926
-279
-0.6% -$21.1K 0.52% 56
2018
Q2 		$3.06M Sell
43,205
-45
-0.1% -$3.18K 0.5% 56
2018
Q1 		$3.26M Buy
43,250
+226
+0.5% +$18K 0.54% 51
2017
Q4 		$3.08M Sell
43,024
-129
-0.3% -$9.8K 0.58% 52
2017
Q3 		$3.5M Buy
43,153
+78
+0.2% +$5.96K 0.7% 47
2017
Q2 		$3.05M Sell
43,075
-717
-2% -$47.7K 0.59% 52
2017
Q1 		$2.97M Sell
43,792
-511
-1% -$35.9K 0.62% 51
2016
Q4 		$3.17M Sell
44,303
-197
-0.4% -$14.6K 0.71% 47
2016
Q3 		$3.52M Sell
44,500
-622
-1% -$50.5K 0.79% 43
2016
Q2 		$3.76M Sell
45,122
-521
-1% -$46.2K 0.93% 37
2016
Q1 		$4.19M Buy
45,643
+14,745
+48% +$1.33M 1.05% 36
2015
Q4 		$3.13M Buy
+30,898
New +$3.22M 1.34% 23

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cardan Capital Partners's GILD Position: Q4 2020 in Review

Cardan Capital Partners sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 49,312 shares — an estimated $3.12M sold.

Cardan Capital Partners first reported a position in GILD in Q4 2015 and held it in 20 quarters. The position peaked at $4.19M in Q1 2016. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Cardan Capital Partners reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Cardan Capital Partners sold 49,312 Gilead Sciences shares in Q4 2020, an estimated $3.12M.
  • Cardan Capital Partners first reported a position in Gilead Sciences in Q4 2015 and held it in 20 quarters.
  • Cardan Capital Partners's Gilead Sciences position peaked at $4.19M in Q1 2016.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Cardan Capital Partners's 13F filing for Q4 2020, filed 27 Jan 2021.